Inclunox 80 mg (Enoxaparin Sodium SOLUTION) 80 MG

Inclunox 80 mg is an enoxaparin sodium solution used for anticoagulation therapy. This intravenous medication helps prevent blood clots, offering a convenient option for those needing blood thinning treatment.

Strength

80 MG

Manufacturer / TM Owner

SANDOZ CANADA INCORPORATED

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Inclunox 80 mg is primarily used for anticoagulation, helping to prevent blood clots in various medical conditions. It is often prescribed for patients undergoing surgery or those at risk of deep vein thrombosis. This medication works by thinning the blood, reducing the likelihood of clot formation. Many people wonder, 'What is Inclunox 80 mg used for?' It is commonly used to manage and prevent conditions related to excessive blood clotting.

Side Effects

Common effects of Inclunox 80 mg may include bruising, bleeding, and pain at the injection site. Some users might experience mild nausea or dizziness. These effects are generally mild and temporary, but any persistent or severe symptoms should be discussed with a healthcare provider.

Precautions & Warnings

Inclunox 80 mg should be handled with care to avoid contamination. It is important to follow proper storage guidelines and use sterile techniques when administering the solution. Patients with a history of bleeding disorders or allergies to enoxaparin sodium should consult their healthcare provider before use.

Avoid Interactions

Inclunox 80 mg may interact with other medications that affect blood clotting, such as aspirin or nonsteroidal anti-inflammatory drugs (NSAIDs). Alcohol consumption should be moderated, as it can increase the risk of bleeding. Always inform your healthcare provider about all medications and supplements you are taking.

Frequently Asked Questions

Inclunox 80 mg is used for anticoagulation therapy to prevent blood clots in various medical conditions.

Inclunox 80 mg is administered intravenously, typically by a healthcare professional.

Common side effects may include bruising, bleeding, and pain at the injection site.

Inclunox 80 mg may interact with other blood-thinning medications, so consult a healthcare provider before combining treatments.

Follow proper storage guidelines and use sterile techniques when administering Inclunox 80 mg.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.